Most drugs used to treat chronic issues dealing with digestion or heart issues carry some risk of side effects, but some are worse than others. Lisinopril is a angiotensin-converting enzyme (ACE) inhibitor, used to treat congestive heart failure, hypertension, and reduce the risk of heart attack. It has been commonly prescribed since the FDA first approved it for patient use in the early 1990s.
In recent years, testosterone therapies to help men with erectile dysfunction or low testosterone levels have become more common than ever. With the advances in such medication, however, come advances in risks that accompany such treatment. According to WebMD.com, testosterone replacement therapy (TRT), are not as common as one may think.
Recently, it was discovered in a study that Depakote use by pregnant women could cause lower IQ scores in their offspring. This is the latest of several suspected Depakote side effects that are ending in lawsuits.
Apnea in Greek means “without breath”. When a person has sleep apnea, their breathing involuntarily stops while they are sleeping. This stopping can happen hundreds of times throughout the night for up to a minute, or longer at a time. Most of the time the person is not aware of their breathing stopping, which means death is a quiet, inevitable occurrence when not treated. Statistics show that one out of fifteen people have some case of sleep apnea. However, one out of fifty go undiagnosed.
Recently, Natural Standard posted an article stating that Rugby Natural Ferrous Sulfate Iron Supplements have been recalled.
The U.S. Food and Drug Administration (FDA) have issued a consumer warning for the iron supplement listed above, which is manufactured by Advance Pharmaceutical Inc.
The firm is currently undergoing an investigation of Zoloft birth defect lawsuits for the families who had a child born with congenital abnormality that is allegedly associated with their mother’s use of Zoloft during her pregnancy.
The new lead free implantable heart defibrillator, invented by Boston Scientific Corp, should not be used on a regular basis until more data is available, according to a story in the Chicago Tribune. Defibrillator leads have often caused problems for device makers.
The FDA is now requiring sleep aids such as Ambien, Ambien CR, Edluar and Zolpimist to lower their dosage. Zolpidem, an ingredient in these brands, may remain in the blood the next morning in high enough levels to impair certain activities that require alertness.
Zolpidem is eliminated slower from women’s bloodstreams, so the FDA is notifying manufacturers to lower the recommended dose for women—and they suggest lowering it for men as well. Especially in the extended-release form, zolpidem can cause problems the following morning for some activities, such as driving.